There have been 30 complaints so far about this issue, including 26 injuries and four deaths.

The FDA has categorized this as a Class I recall, which means using the devices “may cause serious injuries or death.”

Creating these complex structures with 3D printing alone has never been possible—until now. 

The CardioVascular Coalition and Society for Cardiovascular Angiography and Interventions have both issued new statements highlighting their issues with the 2024 MPFS proposed rule. 

Matthew Martinez, MD, detailed the many ways HCM care management is changing during an exclusive interview at ASE 2023.

Researchers tracked data from nearly 7,000 TAVR patients for two years, focusing on all-cause mortality and heart failure hospitalizations.

Researchers think their new AI model could be especially helpful in areas where qualified physicians and/or ultrasound technology are in short supply.

Versanis, founded in 2021 by a venture capital firm, is primarily known as the company behind the obesity drug bimagrumab.

Rep. Mike Carey introduced the Imaging Services Price Transparency Act July 25, hoping to better inform patients about services provided by the specialty. 

Look for AI, 5G and big data analytics to lead all other emerging technologies in reshaping U.S. healthcare over the next several years.